Updates are available Correction dated 2021-11-11
Click to view Correction: https://doi.org/10.1038/s41586-021-04104-y
-
Authors
Correia, Ana Luísa https://orcid.org/0000-0003-2414-0131
Guimaraes, Joao C. https://orcid.org/0000-0002-1664-472X
Auf der Maur, Priska https://orcid.org/0000-0002-9059-8979
De Silva, Duvini
Trefny, Marcel P. https://orcid.org/0000-0001-6755-7899
Okamoto, Ryoko
Bruno, Sandro
Schmidt, Alexander https://orcid.org/0000-0002-3149-2381
Mertz, Kirsten https://orcid.org/0000-0002-3074-6925
Volkmann, Katrin
Terracciano, Luigi
Zippelius, Alfred https://orcid.org/0000-0003-1933-8178
Vetter, Marcus
Kurzeder, Christian
Weber, Walter Paul
Bentires-Alj, Mohamed https://orcid.org/0000-0001-6344-1127
- License Information
-
More Information
Article History
Received: 16 December 2019
Accepted: 4 May 2021
First Online: 2 June 2021
Change Date: 11 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-021-04104-y
Competing interests
: A.L.C., P.A.d.M., M.P.T., R.O., A.S., K.M., K.V., L.T., M.V. and C.K. declare no competing interests. J.C.G. and D.D.S. are employees of F. Hoffmann–La Roche. S.B. is an employee of Novartis. A.Z. received honoraria from Bristol-Myers Squibb, Merck Sharp & Dohme, Hoffmann–La Roche, NBE Therapeutics, Secarna, ACM Pharma and Hookipa. A.Z. maintains non-commercial research agreements with Hoffmann–La Roche. A.Z. maintains further non-commercial research agreements with NBE Therapeutics, Secarna, ACM Pharma, Hookipa and BeyondSpring. M.B.-A. owns equities in and receives laboratory support and compensation from Novartis, and serves as consultant for Basilea. Outside of the submitted work, W.P.W. received research support from Takeda Pharmaceuticals International paid to the Swiss Group for Clinical Cancer Research (SAKK) and personal honoraria from Genomic Health. Support for meetings was paid to his institution from Sandoz, Genomic Health, Medtronic, Novartis Oncology, Pfizer and Eli Lilly.
